文献速递自身炎症与 IgG4 相关病

中国湖北IgG4相关性疾病患者感染COVID-19的临床特征

Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, China.
PubMed 文献 · Semin Arthritis Rheum · 2020-05-16

该研究基于覆盖全国200余例IgG4-RD患者的随访系统,调查了湖北91例IgG4-RD患者中COVID-19的感染情况与临床表现。结果显示91例中2例感染COVID-19,均为中型,症状与影像学特征与其他COVID-19患者相似,持续口服低剂量糖皮质激素下无IgG4-RD复发或进展为重型/危重型,其中1例SARS-CoV-2核酸转阴时间较长。结论提示IgG4-RD患者可能属于COVID-19易感人群,需更仔细的个人防护,早期识别和适当治疗对防止进展为重型非常重要。

要点

  • 湖北91例IgG4-RD患者中2例感染COVID-19,均为中型。
  • 持续口服低剂量糖皮质激素下无IgG4-RD复发或COVID-19重型/危重型进展。
  • 1例患者SARS-CoV-2核酸转阴时间较长。

核心结论

  • IgG4-RD患者可能属于COVID-19感染易感人群,需要更仔细的个人防护。
  • 早期识别和适当治疗对防止IgG4-RD合并COVID-19患者进展为重型非常重要。

研究设计与样本

  • 基于过去十年覆盖全国200余例IgG4-RD患者的随访系统,识别并调查了居住在中国湖北的91例IgG4-RD患者。
  • 通过标准化数据收集表获取病史、临床症状、实验室检查、CT影像和治疗信息,并由两名研究者独立审核。

主要发现

  • 91例IgG4-RD患者中2例感染COVID-19,均分类为中型。
  • 2例患者的发热、咳嗽等症状及影像学特征与其他COVID-19患者相似。
  • 在持续口服低剂量糖皮质激素条件下,2例患者均无IgG4-RD复发,也未进展为COVID-19重型或危重型。
  • 患者2的SARS-CoV-2核酸转阴所需时间较长。

临床怎么用

  • 对IgG4-RD患者应强调更仔细的个人防护以预防COVID-19感染。
  • 对合并COVID-19的IgG4-RD患者应早期识别并适当治疗,以防止进展为重型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: IgG4-related disease (IgG4-RD) is an immune-mediated multi-organ, chronic and progressive disease. Therefore, we conducted a study to investigate the susceptibility of COVID-19 in IgG4-RD patients in Hubei province, and to characterize the clinical manifestation of COVID-19 in IgG4-RD patients. METHODS: A follow-up system that includes over 200 IgG4-RD patients across the country during the past ten years. A total of ninety-one patients with IgG4-RD who live in Hubei, China were identified and responded to our survey. Medical history, clinical symptoms, laboratory tests, CT imaging, and treatment were obtained through a standardized data collection form, and then independently reviewed by two investigators. RESULTS: 2 of 91 cases were infected with COVID-19. Both of them were classified as moderate type. The symptoms such as fever and cough and radiologic features were similar to other COVID-19 patients. Neither of them episode recurrent of IgG4-RD nor progressed to severe or critical condition of COVID-19 under the condition of continuous oral low-dose of glucocorticoids. Besides, patient 2 took a long time for SARS-CoV-2 nucleic acid to turn negative. CONCLUSION: IgG4-RD patients may belongs to the susceptible population of COVID-19 infection, and thus need more careful personal protection. Early identification and properly treatment are very important to prevent IgG4-RD patients with COVID-19 from progression to severe condition.

来源:Semin Arthritis Rheum,查看原文。版权归原作者所有。

引用

  1. Chen Y, Dong Y, Cai S, et al. Clinical characteristics of IgG4-RD patients infected with COVID-19 in Hubei, China. Semin Arthritis Rheum. 2020. PMID: 32425259. doi:10.1016/j.semarthrit.2020.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。